Liver TransplantationViremiaImmunosuppressive AgentsTacrolimusLiver DiseasesLiver FailureGraft RejectionKidney TransplantationEnd Stage Liver DiseaseLiver CirrhosisCyclosporineGraft SurvivalLiver NeoplasmsLiverLiving DonorsPostoperative ComplicationsTissue DonorsTime FactorsTreatment OutcomeRetrospective StudiesLiver Function TestsHepatitis CPostoperative PeriodRecurrenceTransplantationAntiviral AgentsCytochrome P-450 CYP3AMycophenolic AcidHeart TransplantationLiver RegenerationTransplantation, HomologousCarcinoma, HepatocellularFatty LiverMicrosomes, LiverFollow-Up StudiesRisk FactorsCytomegalovirus InfectionsOrgan TransplantationWaiting ListsTransplantsProspective StudiesImmunosuppressionLung TransplantationTissue and Organ ProcurementIncidenceHepacivirusPolyethylene GlycolsLiver Failure, AcuteDrug-Induced Liver InjuryImmunocompromised HostMitochondria, LiverTransplantation ImmunologyBK VirusGenotypeCytomegalovirusLiver CirculationPolyomavirus InfectionsBone Marrow TransplantationViral LoadHepatectomyCalcineurinCadaverCyclosporinsGanciclovirKidneyLiver Diseases, AlcoholicDrug Therapy, CombinationHepatic ArteryBiopsySirolimusLiver ExtractsLiver Cirrhosis, AlcoholicLiver Neoplasms, ExperimentalKidney Failure, ChronicDrug MonitoringLymphoproliferative DisordersAlanine TransaminaseCreatininePortal VeinLiver AbscessAntilymphocyte SerumSurvival AnalysisHistocompatibility TestingOpportunistic InfectionsSurvival RateRisk AssessmentBiliary AtresiaTransplantation ToleranceDonor SelectionKidney DiseasesBronchiolitis ObliteransMycosesMonitoring, ImmunologicHeart-Lung TransplantationDNA, ViralHepatitis C, ChronicPancreas TransplantationPatient SelectionHepatocytesBiological Markers